[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 5 of about 5
1. Gaur S, Trayner E, Aish L, Weinstein R: Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection. Am J Hematol; 2004 Sep;77(1):22-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection.
  • In addition to the expected granulomatous changes, she was found to have a B-cell lymphoma of bronchus associated lymphoid tissue (BALT).
  • Her lymphoma remains suppressed with antimycobacterial therapy 6 months after resection of bulk disease.
  • [MeSH-major] Bronchial Neoplasms / microbiology. Lymphoma, B-Cell / microbiology. Mycobacterium avium. Tuberculosis / complications
  • [MeSH-minor] Aged. Anti-Infective Agents / therapeutic use. Bronchiectasis / complications. Bronchiectasis / drug therapy. Chronic Disease. Ciprofloxacin / therapeutic use. Clarithromycin / therapeutic use. Disease-Free Survival. Female. Humans

  • Genetic Alliance. consumer health - Bronchiectasis.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Clarithromycin .
  • Hazardous Substances Data Bank. CIPROFLOXACIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2004 Wiley-Liss, Inc.
  • (PMID = 15307101.001).
  • [ISSN] 0361-8609
  • [Journal-full-title] American journal of hematology
  • [ISO-abbreviation] Am. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents; 5E8K9I0O4U / Ciprofloxacin; H1250JIK0A / Clarithromycin
  •  go-up   go-down


2. Tanaka K, Migitani A, Teshima H, Tatsumi Y, Inoue T, Ohta K, Yamane T, Hino M, Takubo T, Tatsumi N: [Two cases of bronchus-associated lymphoid tissue lymphoma]. Rinsho Ketsueki; 2001 Dec;42(12):1170-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Two cases of bronchus-associated lymphoid tissue lymphoma].
  • We report 2 cases of bronchus-associated lymphoid tissue lymphoma (BALT lymphoma), which is a rare disease.
  • The patients were therefore diagnosed as having BALT lymphoma.
  • The patients have been followed up after discontinuation of the medication.
  • [MeSH-major] Lymphoma, B-Cell, Marginal Zone

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11828719.001).
  • [ISSN] 0485-1439
  • [Journal-full-title] [Rinshō ketsueki] The Japanese journal of clinical hematology
  • [ISO-abbreviation] Rinsho Ketsueki
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


3. Adam P, Gernert C, Schmitt S, Haralambieva E, Ott G, Müller-Hermelink HK, Hentschel U: [The spectrum of microbiological agents causing pulmonary MALT-type lymphomas. A 16S rRNA-based analysis of microbial diversity]. Pathologe; 2008 Nov;29 Suppl 2:290-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The spectrum of microbiological agents causing pulmonary MALT-type lymphomas. A 16S rRNA-based analysis of microbial diversity].
  • [Transliterated title] Das Erregerspektrum pulmonaler MALT-Typ-Lymphome. Eine 16S-rRNA-basierte Analyse der mikrobiellen Diversität.
  • For several anatomical localisations of extranodal marginal zone B-cell lymphoma of MALT type (eMZBCL), an association with chronic inflammation caused by microbiological agents (e.g.
  • A comprehensive diversity survey using 16S-rDNA library construction followed by restriction fragment length polymorphism (RFLP) analysis, sequencing, and phylogenetic tree construction was employed for nine cases each of BALT lymphoma and control lung tissues (normal foetal lung, pneumonitis, carcinoid).
  • This highly sensitive method, hereafter termed SHARP screening allowed for identification of the entire bacterial population in the tissue in a cultivation-independent manner.
  • It was noteworthy that in eight of the nine cases of BALT lymphoma, bacteria of the Alcaligenaceae family (Alcaligenes, Achromobacter, AKIW733), were detected, whereas none of the control cases showed the presence of these clades.
  • 16S-rDNA library construction in combination with RFLP screening and phylogenetic analyses, hereafter described as SHARP screening, is a cultivation-independent tool for analysing the microbial environment in chronic inflammation processes giving rise to extranodal marginal zone B-cell lymphomas of MALT-type.
  • Betaproteobacteria of the Alcaligenaceae family may be affiliated with and possibly involved in the lymphomagenesis of BALT lymphomas.
  • [MeSH-major] Alcaligenes / genetics. Bacteria / genetics. Bacterial Infections / microbiology. Gram-Negative Bacterial Infections / microbiology. Lung Neoplasms / microbiology. Lymphoma, B-Cell, Marginal Zone / microbiology. RNA, Ribosomal, 16S / genetics

  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucleic Acids Res. 2004 Feb 25;32(4):1363-71 [14985472.001]
  • [Cites] Appl Environ Microbiol. 2002 Sep;68(9):4431-40 [12200297.001]
  • [Cites] J Bacteriol. 1998 Sep;180(18):4765-74 [9733676.001]
  • [Cites] J Cyst Fibros. 2007 Jan;6(1):75-8 [16793350.001]
  • [Cites] J Cutan Pathol. 1997 Sep;24(8):457-61 [9331890.001]
  • [Cites] J Natl Cancer Inst. 2004 Apr 21;96(8):586-94 [15100336.001]
  • [Cites] Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 [9396791.001]
  • [Cites] Microbiol Rev. 1995 Mar;59(1):143-69 [7535888.001]
  • [Cites] N Engl J Med. 2004 Jan 15;350(3):213-5 [14724298.001]
  • [Cites] J Clin Microbiol. 1987 Oct;25(10):1952-5 [3667915.001]
  • [Cites] Science. 1997 May 2;276(5313):734-40 [9115194.001]
  • [Cites] J Pathol. 2006 Jul;209(3):344-51 [16583361.001]
  • [Cites] Important Adv Oncol. 1996;:111-21 [8791131.001]
  • [Cites] Pathologe. 2007 Feb;28(1):6-14 [17211669.001]
  • [Cites] Cancer. 1983 Oct 15;52(8):1410-6 [6193858.001]
  • (PMID = 18854998.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


Advertisement
4. Imai H, Sunaga N, Kaira K, Kawashima O, Yanagitani N, Sato K, Tomizawa Y, Hisada T, Ishizuka T, Hirato J, Saito R, Nakajima T, Mori M: Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma. Intern Med; 2009;48(5):301-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma.
  • OBJECTIVE: Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) type is the most frequent type of non-Hodgkin's lymphoma to primarily involve the lung.
  • Pulmonary MALT lymphoma, also known as bronchial-associated lymphoid tissue (BALT) lymphoma, is a rare disease and the clinicopathological features have yet to be clearly elucidated.
  • PATIENTS AND METHODS: The present study retrospectively reviewed 13 patients (8 men, 5 women) with BALT lymphoma from 3 institutions between 1989 and 2007 to assess clinicopathological features.
  • CONCLUSION: The present study indicates that BALT lymphoma tends to be limited to the lung on the initial diagnosis and responds well to local therapy such as surgery.
  • Prognosis for this lymphoma tends to be indolent.
  • [MeSH-major] Lung / pathology. Lymphoma, B-Cell, Marginal Zone / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Drug Therapy. Female. Humans. Male. Middle Aged. Prognosis. Radiotherapy. Retrospective Studies. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19252351.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


5. Stefanovic A, Morgensztern D, Fong T, Lossos IS: Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database. Leuk Lymphoma; 2008 Jul;49(7):1311-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database.
  • Pulmonary marginal zone lymphoma is a rare disease arising from bronchial-associated lymphoid tissue (BALT).
  • There is limited information on clinical presentation, natural history and treatment of this type of lymphoma.
  • We conducted a retrospective review of patients with biopsy-proven BALT lymphoma treated at our institution and patients from the surveillance epidemiology and end results (SEER) database.
  • Twenty-one patients (median age 57) with disease stage IE (n = 10) and IV (n = 11), were treated at our institution.
  • Initial management included observation (n = 4), surgery (n = 5), combination chemotherapy (n = 7), single-agent rituximab (n = 3) and radioimmunotherapy (n = 2).
  • We identified 326 patients (59% females and 41% males; median age 68 [30 to 85) with BALT lymphoma in the SEER database.
  • Fifty-five per cent had stage IE, 10% stage IIE, 3% stage IIIE, and 22% stage IV disease.
  • [MeSH-major] Lung Neoplasms. Lymphoma, B-Cell, Marginal Zone

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18604720.001).
  • [ISSN] 1029-2403
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA109335; United States / NCI NIH HHS / CA / R01 CA122105
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down






Advertisement